University of Edinburgh seeks - Research Fellow
The Usher Institute at the University of Edinburgh is seeking a highly skilled and motivated epidemiologist/research fellow to work in the field of vascular disease, including both the diagnosis and treatment of peripheral vascular diseases and the development of vascular complications of type 2 diabetes. The primary role will be to undertake a series of high quality systematic reviews on the prevention, diagnosis and treatment of vascular diseases, including abdominal aortic aneurysm, venous thromboembolism and peripheral arterial disease, within the core programme of work which constitutes the CSO funded research project...
Source: Cochrane News and Events - July 22, 2020 Category: Information Technology Authors: Lydia Parsonson Source Type: news

Doxycycline Does Not Cut Growth of Abdominal Aortic Aneurysms
WEDNESDAY, June 3, 2020 -- Doxycycline does not significantly reduce aneurysm growth compared with placebo among patients with small infrarenal abdominal aortic aneurysms, according to a study published in the May 26 issue of the Journal of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 3, 2020 Category: Pharmaceuticals Source Type: news

Temple researchers track new path to therapeutic prevention of abdominal aortic aneurysm
(Temple University Health System) New research by scientists at the Lewis Katz School of Medicine at Temple University suggests that abdominal aortic aneurysm (AAA) can be prevented therapeutically. In work published online May 28 in the journal Cardiovascular Research, they show for the first time in animals that blocking a molecule known as dynamin-related protein 1 (Drp1) can stop AAA from developing. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 28, 2020 Category: Biology Source Type: news

Doxycycline ineffective at shrinking aortic aneurysms in two-year study
(Vanderbilt University Medical Center) Patients with a vascular condition called abdominal aortic aneurysm did not benefit from taking the common antibiotic doxycycline for two years to shrink the aneurysm when compared to those who took a placebo, according to a Vanderbilt University Medical Center (VUMC) study published in the Journal of the American Medical Association (JAMA). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 27, 2020 Category: International Medicine & Public Health Source Type: news

Researchers find no benefit for treatment used to avoid surgery for abdominal aortic aneurysm
(University of Maryland School of Medicine) A new landmark study by researchers at the University of Maryland School of Medicine (UMSOM) found that patients with a vascular condition, called abdominal aortic aneurysm, received no benefits from taking a common antibiotic drug to reduce inflammation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 26, 2020 Category: International Medicine & Public Health Source Type: news

Polygenic Risk Score Helps Target AAA Screening Polygenic Risk Score Helps Target AAA Screening
The score, based on analysis of 29 discrete genetic variants linked with abdominal aortic aneurysms, appeared better than the current criteria that clinicians use to identify people to screen for AAA.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 15, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news

More Medical Device Businesses Impacted by COVID-19
The uncertainty surrounding COVID-19 is making it difficult for public companies to accurately forecast 2020 earnings. Irvine, CA-based Endologix recently joined a growing list of medical device companies that have withdrawn previously-reported financial guidance for the year. The company makes endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once an AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. Endologix said AAA p...
Source: MDDI - April 6, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Aneurysm Diameter, Intraluminal Thrombus Predict AAA Growth
THURSDAY, Feb. 6, 2020 -- Maximum diameter and presence of intraluminal thrombus (ILT) are independent predictors of abdominal aortic aneurysm (AAA) growth, according to a study published online Jan. 28 in Radiology. Chengcheng Zhu, Ph.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 6, 2020 Category: Pharmaceuticals Source Type: news

Presence of Blood Clot Tied to Accelerated AAA Progression Presence of Blood Clot Tied to Accelerated AAA Progression
The maximal diameter of an abdominal aortic aneurysm (AAA) and the presence of an intraluminal thrombus (ILT) are both independent predictors of faster aneurysm growth, according to a new study.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - February 6, 2020 Category: Radiology Tags: Cardiology News Source Type: news

USPSTF Recommends Screening Older Men Who Smoked for AAA
On Dec. 10, the U.S. Preventive Services Task Force posted a final recommendation statement on screening for abdominal aortic aneurysm in asymptomatic patients, with recommendations included in that statement varying based on sex, age, smoking status and family history. (Source: AAFP News)
Source: AAFP News - December 11, 2019 Category: Primary Care Source Type: news

USPSTF Advises AAA Screening Based on Sex, Age, Smoking History
TUESDAY, Dec. 10, 2019 -- The U.S. Preventive Services Task Force (USPSTF) recommendations for abdominal aortic aneurysm (AAA) screening vary by sex, smoking status, and family history. These recommendations form the basis of a final recommendation... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 10, 2019 Category: Pharmaceuticals Source Type: news

FDA Issues Safety Alert for Endologix AAA Duraply Repair Grafts FDA Issues Safety Alert for Endologix AAA Duraply Repair Grafts
The FDA warns of potentially higher risk for type III endoleaks with two Endologix endovascular grafts that use Duraply graft material to repair of abdominal aortic aneurysm.News Alerts (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - October 28, 2019 Category: Cardiology Tags: Cardiology News Alert Source Type: news

Sex Disparity in Abdominal Aortic Aneurysm Repair Outcomes Sex Disparity in Abdominal Aortic Aneurysm Repair Outcomes
Do sex-related differences exist in mortality after repair of ruptured abdominal aortic aneurysm? Is the timeliness of repair a factor?Annals of Surgery (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 25, 2019 Category: Surgery Tags: General Surgery Journal Article Source Type: news

Endologix Takes a Step Forward with Nellix IDE
Endologix has received investigational device exemption (IDE) approval from FDA for a new pivotal study to evaluate the safety and effectiveness of the Nellix Chimney Endovascular Aneurysm Sealing System for the endovascular treatment of complex abdominal aortic aneurysms (AAA). The system is an endovascular abdominal aortic aneurysm therapy designed to combine the Nellix 3.5 endograft with parallel visceral stents to enable treatment of patients with juxta-renal, para-renal, and suprarenal AAA. The application of endovascular aneurysm sealing for patients with complex aneurysms will offer innovativ...
Source: MDDI - August 9, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Regulatory and Compliance Source Type: news

USPSTF Recommends Screening Older Men Who Smoked for AAA
On June 18, the U.S. Preventive Services Task Force posted a draft recommendation statement on screening for abdominal aortic aneurysm in asymptomatic patients. Men ages 65-75 who smoke or used to smoke benefit most from screening; the task force recommends one-time screening with ultrasonography in this group. (Source: AAFP News)
Source: AAFP News - July 8, 2019 Category: Primary Care Source Type: news

USPSTF Addresses Screening for Abdominal Aortic Aneurysm
TUESDAY, June 18, 2019 -- The U.S. Preventive Services Task Force (USPSTF) recommendations on screening for abdominal aortic aneurysm (AAA) vary with sex, age, smoking status, and family history. These recommendations form the basis of a draft... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 18, 2019 Category: Pharmaceuticals Source Type: news

GMED Reinstates CE Mark for Endologix Nellix System
Endologix reported a huge regulatory win this week. The Irvine, CA-based company said its CE mark for the Nellix EndoVascular Aneurysm Sealing System has been reinstated, allowing the device to return to the European market. In January, Endologix initiated a voluntary recall of the existing inventory of its Nellix endovascular aneurysm sealing system. The company decided to limit the device to use under clinical protocol with pre-screened patients that adhere to the current indications. The company's CE mark for the Nellix system was subsequently suspended. Endologix said the reinstateme...
Source: MDDI - June 7, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Long-Term Survival Similar for Endovascular, Open AAA Repair
WEDNESDAY, May 29, 2019 -- For patients with asymptomatic abdominal aortic aneurysm, long-term overall survival is similar with either endovascular repair or open repair, according to a study published in the May 30 issue of the New England Journal... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 29, 2019 Category: Pharmaceuticals Source Type: news

Adult Health Screening
This report summarises evidence on the management of four screening programmes in England: bowel cancer, breast cancer, cervical cancer and abdominal aortic aneurysm. The report finds that the Department of Health and Social Care, NHS England and Public Health England are not doing enough to make sure that everyone who is eligible to take part in screening is doing so, and do not know if everyone who should be invited for screening has been (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 13, 2019 Category: Consumer Health News Source Type: news

Virtual reality engages patients more than CT, booklets
Patients with an abdominal aortic aneurysm were more engaged and had a better...Read more on AuntMinnie.comRelated Reading: 4 practical applications of VR, AR in radiology SIR: Virtual reality beats fluoroscopy for catheter placement VR, AR elevate radiologists' value in future of medicine Virtual reality may help plan, guide glioma resection VR software may increase MRI segmentation efficiency (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 25, 2019 Category: Radiology Source Type: news

Endologix readies for 1-for-10 reverse split
Endologix (NSDQ:ELGX) said yesterday that its board of directors set the ratio for its reverse stock split at 1-for-10. Beginning today, Endologix’s common stock will trade on the Nasdaq Global Select market on a reverse stock split-adjusted basis, the Irvine, Calif.-based company reported. Following the reverse split, there will be roughly 10.3 million shares of issued and outstanding common stock, according to Endologix. The company’s stock will continue to trade under the ‘ELGX’ ticker. In February, Endologix posted fourth-quarter and full-year results that missed sales and earnings estimate...
Source: Mass Device - March 6, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Featured Stent Grafts Wall Street Beat Endologix Source Type: news

Endologix misses the mark with Q4, 2018 numbers
The objectives we accomplished during the second half of 2018 align with those we laid out during our second-quarter earnings call as part of our strategic reset. As we enter 2019, our single biggest lever will be a consistent and unwavering application of individual and company-wide accountability. We will lean heavily on this lever throughout the year as the critical enabler of consistent delivery on our commitments to patients, customers, investors and other stakeholders. We are determined to sustain the momentum generated over the last two quarters as we continue to take steps to improve the company’s operational...
Source: Mass Device - February 27, 2019 Category: Medical Devices Authors: Brad Perriello Tags: MassDevice Earnings Roundup Stent Grafts Wall Street Beat Endologix Source Type: news

How Endologix Is Winning Customers Back One Procedure at a Time
Endologix might not be out of the woods yet, but the company does appear to be moving in the right direction. "We are shifting from a defensive position to an offensive position," CEO John Onopchenko said during the company's fourth-quarter earnings call on Monday, as transcribed by Seeking Alpha. The company reported sequential sales growth of its Ovation system in the fourth quarter, which management said gives them confidence that the platform will return Endologix to growth in the second half of 2019. But to fully appreciate that projection, investors have to look back at where the Irvine, CA-base...
Source: MDDI - February 26, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Why 20% of men ignore the test that'll stop them dropping dead?
Abdominal aortic aneurysm, or AAA, is a swelling of the body ’s biggest blood vessel, the aorta, which runs directly from the heart to the lower body. If it bursts, 8 out of 10 victims die. (Source: the Mail online | Health)
Source: the Mail online | Health - February 10, 2019 Category: Consumer Health News Source Type: news

Why 20% of men ignore the test that'll stop them dropping dead?
Abdominal aortic aneurysm, or AAA, is a swelling of the body’s biggest blood vessel, the aorta, which runs directly from the heart to the lower body. If it bursts, 8 out of 10 victims die. (Source: the Mail online | Health)
Source: the Mail online | Health - February 10, 2019 Category: Consumer Health News Source Type: news

Endologix ’s CE Mark for Nellix is Suspended
It looks like more bad news for Endologix.  The Irvine, CA-based company said its CE Mark for the Nellix EndoVascular Aneurysm Sealing System has been suspended by its Notified Body, GMED. Endologix first received approval in Europe for the device in 2013. The Nellix system was developed as an alternative treatment to traditional endovascular aneurysm repair for an abdominal aortic aneurysm. The system is designed to seal an entire aneurysm. “The notification from GMED is a regulatory action and is not in response to any new information beyond our recent FSN,” Dr. Matt Thomps...
Source: MDDI - January 25, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Regulatory and Compliance Source Type: news

Endologix Voluntarily Recalls Nellix
Endologix said it was initiating a voluntary recall of the existing inventory of its Nellix endovascular aneurysm sealing system. The Irvine, CA-based company said it was limiting the device to only be available for use under clinical protocol with pre-screened patients that adhere to the current indications. Endologix said it was taking these steps in order to ensure optimal outcomes for patients. This decision is one of several actions taken by Endologix following a new management mandate in August 2018 to ensure the most appropriate use of each of its devices and is in alignment with a recent publication by the European...
Source: MDDI - January 6, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Regulatory and Compliance Source Type: news

Endologix recalls Nellix stent graft, bans off-label use
Endologix (NSDQ:ELGX) said today that it’s halting the unrestricted sale of its Nellix stent graft for treating abdominal aortic aneurysms and limiting its use to pre-screened patients under a clinical protocol. “We monitor the performance of the Nellix system through clinical trials, our complaint monitoring system, physician interaction and available publications,” CMO Dr. Matt Thompson said in prepared remarks. “Our independently adjudicated data from the EVAS1 IDE clinical trial indicates that the Nellix system has performed well when used consistent with the current indications. However, d...
Source: Mass Device - January 4, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Featured Recalls Regulatory/Compliance Stent Grafts Endologix Source Type: news

Aortica touts FDA clearance to use Medtronic ’ s Valiant Navion in AAA IDE study
Aortica said today that the FDA approved the use of Medtronic‘s (NYSE:MDT) Valiant Navion stent graft system alongside Aortica’s AortaFit in a physician sponsored IDE study. The study, being run by principal investigator Dr. Benjamin Starnes at the University of Washington, will now use the Valiant Navion as a platform for fenestrated endovascular repair together with the AortaFit automated case planning software. “I am excited to bring Medtronic’s Navion into this study. The device architecture incorporates many of the features we feel are important to simplifying fenestrated EVAR and addressi...
Source: Mass Device - December 17, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Food & Drug Administration (FDA) Vascular Aortica Medtronic Source Type: news

In Abdominal Aortic Aneurysm Repair, Curcumin Lacks Benefit
FRIDAY, Nov. 9, 2018 -- When used perioperatively in elective abdominal aortic aneurysm repair, curcumin has no beneficial effect, according to a study published in the Oct. 29 issue of CMAJ, the journal of the Canadian Medical Association. Amit X.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 9, 2018 Category: Pharmaceuticals Source Type: news

Cardinal Health ’ s Cordis launches Mynx Control vascular closure system
Cardinal Health (NYSE:CAH) subsidiary Cordis said last Friday that it launched the Mynx Control vascular closure device intended for sealing 5-7 French femoral arterial access sites. The newly launched system is intended to reduce time to hemostasis and ambulation after diagnostic or interventional procedures, the Dublin, Ohio-based company said. The system also includes a next-generation deployment system designed to improve predictable deployment. “The notion of secure extravascular closure with nothing left behind is very appealing for a number of reasons. In addition to the clinical benefits o...
Source: Mass Device - November 5, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Vascular Cardinal Health Cordis Corp. Source Type: news

No Benefit of Curcumin in Abdominal Aortic Aneurysm Repair No Benefit of Curcumin in Abdominal Aortic Aneurysm Repair
Perioperative oral curcumin does not prevent inflammation or complications in patients undergoing elective abdominal aortic aneurysm repair and may increase risk of postoperative kidney injury.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 1, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Nick Foster obituary
My father, Nick Foster, who has died aged 61 after suffering a ruptured abdominal aortic aneurysm, was an agricultural engineer devoted to improving conditions for rural people in the developing world.He wanted to empower communities by encouraging participation and education, and established water-user groups that led to the sustainable management of irrigation schemes.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - October 15, 2018 Category: Science Authors: Patrick Foster-Devaney Tags: Agriculture Access to water Bangor University Source Type: news

FDA: Endologix recall of AFX stent graft is Class I
Endologix (NSDQ:ELGX) said late last week that the FDA classified its voluntary recall of AFX Endovascular abdominal aortic aneurysm stent graft systems as Class I. Class I recall designations, the FDA’s most serious classification of recall, are used when there is a reasonable probability that product use could cause serious adverse health consequences or death. The Irvine, Calif.-based company said it issued its recall action in July, sending safety notices to healthcare professionals who use the system. The notice included updated information on comparative Type III endoleak rates associated with the device, ...
Source: Mass Device - October 9, 2018 Category: Medical Devices Authors: Fink Densford Tags: Featured Food & Drug Administration (FDA) Recalls Regulatory/Compliance Vascular Endologix Source Type: news

Teleflex picks up Essential Medical and its Manta vascular closure device
Teleflex (NYSE:TFX) said yesterday that it acquired Essential Medical and its Manta vascular closure device for an unspecified amount. Manta is designed to close punctures at femoral arterial access sites after catheterization procedures, including transcatheter aortic valve replacements, endovascular treatment of abdominal aortic aneurysms, ventricular assist procedures and balloon aortic valvuloplasties. Exton, Pa.-based Essential won CE Mark approval in the European Union for Manta in July 2016 and is seeking pre-market approval from the FDA. The federal safety watchdog granted an investiga...
Source: Mass Device - October 5, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Featured Mergers & Acquisitions Vascular Wall Street Beat Essential Medical Devices Teleflex Source Type: news

Statins Improve Long-Term Survival After AAA Repair
THURSDAY, Sept. 20, 2018 -- Preoperative statin therapy is associated with higher long-term survival following abdominal aortic aneurysm (AAA) repair, according to a study published in the August issue of the Journal of Vascular Surgery. Thomas F.X.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 20, 2018 Category: Pharmaceuticals Source Type: news

Gore ’s aneurysm device for tricky anatomies implanted in Europe
(Image courtesy of W.L. Gore & Associates) The first European patient with a challenging anatomy has had the Gore Excluder conformable abdominal aortic aneurysm (AAA) endoprosthesis implanted, according to W.L. Gore & Associates. The next-generation endovascular aneurysm repair (EVAR) device is indicated to treat the broadest range of abdominal aortic aneurysms in patients with difficult anatomies. They include patients with proximal aortic neck angles of up to 90 degrees with a minimum 15 mm aortic neck length and patients with proximal aortic neck angles of up to 60 degrees with a 10 mm minimum aortic n...
Source: Mass Device - September 17, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Cardiovascular Implants Surgical W.L. Gore & Associates Source Type: news

Personal Genome Can Predict Abdominal Aortic Aneurysm Risk Personal Genome Can Predict Abdominal Aortic Aneurysm Risk
Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 12, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Declining Sales Prompts Endologix to Hit the Strategic Reset Button
John Onopchenko has had his work cut out for him since being promoted to CEO of Endologix in May. The company's revenue dropped 6.1% in the fiscal year 2017 compared to the fiscal year 2016 after a manufacturing glitch interrupted sales of its top-selling device for abdominal aortic aneurysms (AAA). This and other issues led CEO John McDermott to resign earlier this year. "The leadership team and I have been working hard on reestablishing Endologix's credibility and reputation with our physicians and customers and building a culture of accountability, with the ultimate goal of deliv...
Source: MDDI - August 14, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Total, Open Repairs Decline for Abdominal Aortic Aneurysms
TUESDAY, July 31, 2018 -- The number of open abdominal aortic aneurysm (AAA) repairs dropped by almost 80 percent during the last decade, according to a study published in the June issue of the Journal of Vascular Surgery. Bjoern D. Suckow, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 31, 2018 Category: Pharmaceuticals Source Type: news

Out with the Old, in with the ... Newish?
  It takes a strong leader to admit when his time is up. Endologix CEO John McDermott is that type of leader, which he proved this week with the announcement that he will be stepping down as CEO of the struggling endovascular aneurysm repair (EVAR) company.     Endologix has had its fair share of hurdles over the past couple of years, but it seems like things might finally be looking up for the Irvine, CA-based company. In May, the company promoted John Onopchenko to the role of CEO. Prior to the promotion, Onopchenko was the company's chief operating officer, a p...
Source: MDDI - July 16, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Benefit of Screening for Abdominal Aortic Aneurysm May Not Outweigh Harms Benefit of Screening for Abdominal Aortic Aneurysm May Not Outweigh Harms
Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - July 5, 2018 Category: Radiology Tags: Cardiology News Source Type: news

Benefit May Not Outweigh Harm in AAA Screening Benefit May Not Outweigh Harm in AAA Screening
Swedish study finds screening for abdominal aortic aneurysm has no statistically significant effect on mortality, suggesting that other factors play a part in AAA incidence and death.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 27, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Opioids and OD; Test for Diabetes: It's PodMed Double T! (with audio)
(MedPage Today) -- This week's topics include the emotional consequences of gun violence, a single test to diagnose diabetes, use of medicines to help addiction after opioid overdose, and screening for abdominal aortic aneurysm (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - June 23, 2018 Category: Psychiatry Source Type: news

FDA Issues Leak Safety Alert for Endologix AAA Repair Grafts FDA Issues Leak Safety Alert for Endologix AAA Repair Grafts
Regulators say the company's AFX endovascular graft system with Strata material -- used for abdominal aortic aneurysm repair -- is at greater risk for type III endoleaks compared with other devices for the same indication.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 19, 2018 Category: Consumer Health News Tags: Cardiology News Alert Source Type: news

Value of AAA screening drops as smoking declines
Mortality from abdominal aortic aneurysms (AAAs) has dropped sharply over the...Read more on AuntMinnie.comRelated Reading: POCUS helps medical students find more AAAs than surgeons USPSTF to take another look at AAA screening Current AAA screening strategies may miss the mark Vascular surgery society cautions use of US in AAA USPSTF finalizes AAA screening recommendations (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 15, 2018 Category: Radiology Source Type: news

Cardinal Health deals majority stake in NaviHealth to PE shop CD & R
Cardinal Health (NYSE:CAH) said this week it divested itself of its majority stake in NaviHealth to private equity firm Clayton, Dubilier & Rice, with Cardinal Health retaining the call right to reacquire the business. NaviHealth provides post-acute car programs to hospital systems, health planst, physician groups and healthcare providers as part of value-based care programs, Cardinal Health said. Through the deal, CD&R will obtain a 55% ownership stake in NaviHealth, while Dublin, Ohio-based Cardinal Health will retain an approximate 45% stake in the post-acute care focused business. “This new investmen...
Source: Mass Device - June 15, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Cardinal Health Source Type: news

Screen Does Not Cut Abdominal Aortic Aneurysm Mortality in Men
FRIDAY, June 15, 2018 -- Screening men for abdominal aortic aneurysm (AAA) does not reduce AAA-related mortality, according to a study published in the June 16 issue of The Lancet. Minna Johansson, M.D., from the University of Gothenburg in Sweden,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 15, 2018 Category: Pharmaceuticals Source Type: news

FDA panel backs Cardinal Health ’ s Incraft stent graft
Cardinal Health (NYSE:CAH) said this week that the FDA Circulatory System Devices Panel of its Medical Devices Advisory Committee issued a favorable recommendation on the premarket approval application for the company’s Incraft abdominal aortic aneurysm stent graft system. The panel voted 11 to 4 in favor of the Incraft system, which is designed as an advanced endovascular aneurysm system for treating infrarenal abdominal aortic aneurysms, the Dublin, Ohio-based company said. The Incraft AAA system differs from other EVAR systems as it is intended to treat a wider range of patients, as many EVAR devices are limi...
Source: Mass Device - June 14, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Stent Grafts Vascular Cardinal Health Source Type: news

Cardinal Health ’ s Cordis wins date with FDA panel for Incraft AAA stent graft
Cardinal Health (NYSE:CAH) subsidiary Cordis this week won a June date with an FDA panel looking to discuss the premarket approval application for its InCraft AAA stent graft system designed for treating infrarenal abdominal aortic aneurysms. On June 12, the FDA’s Medical Device Advisory Committee’s Circulatory Systems Devices Panel will meet to discuss possible marketing applications for the InCraft, which is currently under evaluation in the company’s Inspiration study. The Inspiration study has already met its primary safety and effectiveness endpoints, but reported a higher than anticipated ...
Source: Mass Device - May 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Regulatory/Compliance Stent Grafts Vascular Cardinal Health Cordis Corp. Source Type: news